Article Excerpt: A generative artificial intelligence (Gen-AI)–powered therapy chatbot known as Therabot was associated with significant reductions in several mental health conditions, including major depressive disorder (MDD).
Developed by members of the investigative team, Therabot is a mobile app that allows users to interact with a digital presence they understand is not a real person. Using user prompts and conversation history, the chatbot delivers tailored dialogue, including empathetic responses and targeted questions…
“The effect sizes weren’t just significant, they were huge and clinically meaningful — and mirrored what you’d see in a gold-standard dose of evidence-based treatment delivered by humans over a longer period of time,” senior study author Nicholas Jacobson, PhD, associate professor of biomedical data science and psychiatry at Dartmouth College’s Geisel School of Medicine, Hanover, New Hampshire, told Medscape Medical News.
Full Article: https://tinyurl.com/2hnzpj4h
Article Source: Medscape Medical News